Search for: "State v. Lilly"
Results 581 - 600
of 912
Sorted by Relevance
|
Sort by Date
13 Feb 2015, 1:13 pm
The Pennsylvania case is Kristufek v. [read post]
22 May 2017, 1:00 am
Eli Lilly & Co v Actavis UK Ltd & Ors, heard 4-6 Apr 2017. [read post]
17 Mar 2014, 5:13 pm
As such, the Federal Circuit distinguished the instant case from Eli Lilly & co. v. [read post]
17 Feb 2010, 5:10 am
USA, Inc; Eli Lilly & Co. v. [read post]
8 May 2017, 1:00 am
Eli Lilly & Co v Actavis UK Ltd & Ors, heard 4-6 Apr 2017. [read post]
7 Dec 2014, 3:29 pm
Among the significant –- but, really, very-well indexed –- number of issues, the decision delves into novelty, inventive step, insufficiency by excessive claim breadth, added matter, and claim construction in light of the influential Actavis v Eli Lilly, another Arnoldian decision that the very same judge clarifies further in this ruling. [read post]
28 Dec 2007, 1:00 am
: (IPBiz),Sinorgchem v. [read post]
4 Jan 2013, 12:53 pm
Eli Lilly & Co., 2012 WL 6681895 (Mag. [read post]
11 Nov 2022, 9:40 am
Light Co. v. [read post]
27 Jan 2010, 3:00 am
- ‘indirect consumer tax’ to fund UN public health initiatives (Afro-IP) Canada: Submissions on Canada-EU trade deal: Canadian Generic Pharma Assoc. wants IP out (Michael Geist) Canada: Intellectual property and agriculture – CDC Triffid seed story (ipblog.ca) EU: Records of the 1st, 2nd and 3rd expert meetings on SPCs (The SPC Blog) EU: Cooperation between Board of Appeal and National Court / acceleration of appeal proceedings: Human Genome Sciences v Eli Lilly… [read post]
15 Aug 2010, 11:19 am
State Department. [read post]
10 Sep 2018, 1:20 am
’“ 3) International Investment Arbitration, the European Patent Office, and the Future Unified Patent Court by Thomas Musmann “Since the Eli Lilly v. [read post]
10 Sep 2018, 1:25 am
’“ 3) International Investment Arbitration, the European Patent Office, and the Future Unified Patent Court by Thomas Musmann “Since the Eli Lilly v. [read post]
13 Nov 2014, 5:00 am
Eli Lilly & Co., ___ F. [read post]
9 Jun 2014, 10:08 pm
Eli Lilly & Co., 598 F.3d 1336, 1351 (Fed. [read post]
7 Jul 2010, 5:14 am
(Patent Docs) (Holman's Biotech IP Blog) US: AMP v USPTO after Bilski v Kappos (Patent Docs) US: NORD Chair/HP&M Director presents opening testimony at first ever FDA orphan drug hearing (FDA Law Blog) US: Celsis files patent infringement complaint against CellzDirect and Invitrogen over pooled multi-cryopreserved hepatocyte products (Patent Docs) Products Astelin (Azelastine) – US: Zydus admits infringing Meda’s Astelin patent, agrees not to market… [read post]
6 Jul 2010, 6:03 pm
(Patent Docs) (Holman’s Biotech IP Blog) US: AMP v USPTO after Bilski v Kappos (Patent Docs) US: NORD Chair/HP&M Director presents opening testimony at first ever FDA orphan drug hearing (FDA Law Blog) US: Celsis files patent infringement complaint against CellzDirect and Invitrogen over pooled multi-cryopreserved hepatocyte products (Patent Docs) Products Astelin (Azelastine) – US: Zydus admits infringing Meda’s Astelin patent, agrees not to market… [read post]
24 Feb 2011, 1:49 pm
The plaintiff also advanced Arkansas state pharmacy regulations, but none of these created any duty of pharmacists to warn either patients or prescribing physicians. [read post]
13 Nov 2019, 6:58 am
H.R. 2831, the Lilly Ledbetter Fair Pay Act is Congress’s response. [read post]
1 Oct 2020, 8:00 am
Connick v. [read post]
